Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 38 Records) |
| Query Trace: Neuroendocrine Tumors and MEN1[original query] |
|---|
| Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel. Oncotarget 2017 Nov 8 (55): 93464-93475. Gleeson Ferga C, Voss Jesse S, Kipp Benjamin R, Kerr Sarah E, Van Arnam John S, Mills John R, Marcou Cherisse A, Schneider Amber R, Tu Zheng Jin, Henry Michael R, Levy Michael |
| Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database. Endocrine 2018 3 62 (1): 215-233. Marini Francesca, Giusti Francesca, Fossi Caterina, Cioppi Federica, Cianferotti Luisella, Masi Laura, Boaretto Francesca, Zovato Stefania, Cetani Filomena, Colao Annamaria, Davì Maria Vittoria, Faggiano Antongiulio, Fanciulli Giuseppe, Ferolla Piero, Ferone Diego, Loli Paola, Mantero Franco, Marcocci Claudio, Opocher Giuseppe, Beck-Peccoz Paolo, Persani Luca, Scillitani Alfredo, Guizzardi Fabiana, Spada Anna, Tomassetti Paola, Tonelli Francesco, Brandi Maria Lui |
| Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times. Gastroenterology 2018 2 154 (8): 2060-2063.e8. Roy Somak, LaFramboise William A, Liu Ta-Chiang, Cao Dengfeng, Luvison Alyssa, Miller Caitlyn, Lyons Maureen A, O'Sullivan Roderick J, Zureikat Amer H, Hogg Melissa E, Tsung Allan, Lee Kenneth K, Bahary Nathan, Brand Randall E, Chennat Jennifer S, Fasanella Kenneth E, McGrath Kevin, Nikiforova Marina N, Papachristou Georgios I, Slivka Adam, Zeh Herbert J, Singhi Aatur |
| UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French Population. The Journal of clinical endocrinology and metabolism 2018 10 104 (3): 753-764. Romanet Pauline, Mohamed Amira, Giraud Sophie, Odou Marie-Françoise, North Marie-Odile, Pertuit Morgane, Pasmant Eric, Coppin Lucie, Guien Céline, Calender Alain, Borson-Chazot Françoise, Béroud Christophe, Goudet Pierre, Barlier An |
| The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors. Journal of gastrointestinal oncology 2019 8 10 (4): 645-651. Nuñez Jose Eduardo, Donadio Mauro, Filho Duilio Rocha, Rego Juliana Florinda, Barros Milton, Formiga Maria Nirvana, Lopez Rossana, Riechelmann Rach |
| True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome. Endocrine 2019 May . Kövesdi Annamária, Tóth Miklós, Butz Henriett, Szücs Nikolette, Sármán Beatrix, Pusztai Péter, Toke Judit, Reismann Péter, Fáklya Mónika, Tóth Géza, Somogyi Anikó, Borka Katalin, Erdei Annamária, Nagy Endre V, Deák Veronika, Valkusz Zsuzsanna, Igaz Péter, Patócs Attila, Grolmusz Vince Korn |
| SET domain containing 1B gene is mutated in primary hepatic neuroendocrine tumors. International journal of cancer 2019 4 145 (11): 2986-2995. Yang Penghui, Huang Xuanlin, Lai Chengcai, Li Lin, Li Tieling, Huang Peide, Ouyang Songying, Yan Jin, Cheng Sijie, Lei Guanglin, Wang Zhaohai, Yu Linxiang, Hong Zhixian, Li Ruisheng, Dong Hui, Wang Cheng, Yu Yinghao, Wang Xuan, Li Xianghong, Wang Liming, Lv Fudong, Yin Ye, Yang Huanming, Song Jianxun, Gao Qiang, Wang Xiliang, Zhang Shaoge |
| Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism? European journal of endocrinology 2019 11 182 (1): 57-65. Coppin Lucie, Dufosse Margaux, Romanet Pauline, Giraud Sophie, North Marie-Odile, Cardot Bauters Catherine, Borson-Chazot Françoise, Duchesne Laurence, Métallo Mélanie, Lovecchio Tonio, Barlier Anne, Odou Marie-Françoi |
| Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors. Annals of surgery 2019 10 274 (6): e949-e956. Uemura Jun, Okano Keiichi, Oshima Minoru, Suto Hironobu, Ando Yasuhisa, Kumamoto Kensuke, Kadota Kyuichi, Ichihara Shuji, Kokudo Yasutaka, Maeba Takashi, Nanno Yoshihide, Toyama Hirochika, Takada Yasutsugu, Shimada Mitsuo, Hanazaki Kazuhiro, Masaki Tsutomu, Suzuki Yasuyu |
| Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability. JCO precision oncology 2019 1 2018 . Raj Nitya, Shah Ronak, Stadler Zsofia, Mukherjee Semanti, Chou Joanne, Untch Brian, Li Janet, Kelly Virginia, Saltz Leonard B, Mandelker Diana, Ladanyi Marc, Berger Michael F, Klimstra David S, Reidy-Lagunes Diane, Osoba Muyin |
| ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1). The Journal of clinical endocrinology and metabolism 2020 9 105 (12): e4531-42. Damjanovic Svetozar S, Antic Jadranka A, Elezovic-Kovacevic Valentina I, Dundjerovic Dusko M, Milicevic Ivana T, Beleslin-Cokic Bojana B, Ilic Bojana B, Rodic Gordana S, Berthon Annabel, Maria Andrea Gutierrez, Faucz Fabio R, Stratakis Constantine |
| Pancreatic grade 3 neuroendocrine tumors behave similarly to neuroendocrine carcinomas following resection: a multi-center, international appraisal of the WHO 2010 and WHO 2017 staging schema for pancreatic neuroendocrine lesions. HPB : the official journal of the International Hepato Pancreato Biliary Association 2020 2 22 (9): 1359-1367. Worth Patrick J, Leal Julie, Ding Qian, Trickey Amber, Dua Monica M, Chatzizacharias Nikolaos, Soonawalla Zahir, Athanasopoulos Panagiotis, Toumpanakis Christos, Hansen Paul, Parks Rowan W, Connor Saxon, Parker Kate, Koea Jonathan, Srinavasa Sanket, Ielpo Benedetto, Vicente Lopez Emilio, Lawrence Benjamin, Visser Brendan C, |
| Alternative Lengthening of Telomeres Phenotype Predicts Progression Risk in Noninsulinomas in a Chinese Cohort. Neuroendocrinology 2021 8 112 (5): 510-522. Ban Xinchao, Mo Shengwei, Lu Zhaohui, Jia Congwei, Shao Huilin, Yan Jie, Chang Xiaoyan, Mao Xinxin, Wu Yan, Zhang Yue, Fan Xiaojie, Yu Shuangni, Chen J |
| A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype-Phenotype Correlations. Frontiers in endocrinology 2021 12 681013. Soczomski Przemys?aw, Jurecka-Lubieniecka Beata, Krzywon Aleksandra, Cortez Alexander Jorge, Zgliczynski Stanis?aw, Rogozik Natalia, Oczko-Wojciechowska Ma?gorzata, Pawlaczek Agnieszka, Bednarczuk Tomasz, Jarzab Barba |
| A Parathyroid-Gut Axis: Hypercalcemia and the Pathogenesis of Gastrinoma in Multiple Endocrine Neoplasia 1. Molecular cancer research : MCR 2021 3 19 (6): 946-949. Hackeng Wenzel M, Dreijerink Koen M A, Offerhaus G Johan A, Brosens Lodewijk A |
| Mutation and Expression of Gene YY1 in Pancreatic Neuroendocrine Tumors and Its Clinical Significance. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2021 3 27 (9): 874-880. Song Yu-Li, Xu Jin, Zhao Da-Chun, Zhang Tai-Ping, Jin Kai-Zhou, Zhu Li-Ming, Yu Shuang, Chen Yuan-J |
| DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association. Communications biology 2021 2 4 (1): 155. Lakis Vanessa, Lawlor Rita T, Newell Felicity, Patch Ann-Marie, Mafficini Andrea, Sadanandam Anguraj, Koufariotis Lambros T, Johnston Rebecca L, Leonard Conrad, Wood Scott, Rusev Borislav, Corbo Vincenzo, Luchini Claudio, Cingarlini Sara, Landoni Luca, Salvia Roberto, Milella Michele, Chang David, Bailey Peter, Jamieson Nigel B, Duthie Fraser, Gingras Marie-Claude, Muzny Donna M, Wheeler David A, Gibbs Richard A, Milione Massimo, , , Pederzoli Paolo, Samra Jaswinder S, Gill Anthony J, Johns Amber L, Pearson John V, Biankin Andrew V, Grimmond Sean M, Waddell Nicola, Nones Katia, Scarpa Al |
| Sex-Based Clinicopathologic and Survival Differences Among Patients with Pancreatic Neuroendocrine Tumors. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2022 8 26 (11): 2321-2329. Greenberg Jacques A, Ivanov Nikolay A, Egan Caitlin E, Lee Yeon Joo, Zarnegar Rasa, Fahey Thomas J, Finnerty Brendan M, Min Irene |
| Convergence between germline and somatic mutations in pancreatic neuroendocrine tumors. European journal of endocrinology 2022 5 187 (1): 85-90. Ling Chao, Hong Xiafei, Xu Mengyue, Wang Yutong, Ma Xiaosen, Cui Yunying, Jiang Rui, Cao Dingyan, Wu Huanwen, Tong Anli, Zhao Yupei, Wu Wenmi |
| Management and Long-Term Follow-Up of Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1: Single Center Experience. Journal of clinical medicine 2022 4 11 (7): . Yavropoulou Maria P, Vlachou Sofia, Tsoli Marina, Fostira Florentia, Kaltsas Gregory, Kassi E |
| The Importance of Periodical Screening for Primary Hyperparathyroidism in a Pituitary Tumor Cohort in Searching Patients With MEN1 and Its Genetic Profile. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2022 Mar . Damianse Sabrina S P, Nascimento Gilvan C, Rocha Viviane C C, Nascimento Ana Gisélia P A C, Gaido Nadja C, Azulay Rossana S S, Dos Santos Wellyandra C, Rodrigues Vandilson P, Quidute Ana Rosa P, Magalhães Marcelo, Dos S Faria Manu |
| Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutation. BMC endocrine disorders 2022 3 22 (1): 64. Welsch Christoph, Flügel Anna Katharina, Rondot Susanne, Schulze Egbert, Sircar Ishani, Nußbaumer Judith, Bojunga Jö |
| [MEN for multiple endocrin neoplasms: When evokate MEN? Update 2022]. La Revue de medecine interne 2022 10 44 (1): 12-18. Duval M, Haissaguerre |
| Germline CDKN1B variant type and site are associated with phenotype in MEN4. Endocrine-related cancer 2022 10 30 (1): . Halperin Reut, Arnon Liat, Nasirov Sapir, Friedensohn Limor, Gershinsky Michal, Telerman Alona, Friedman Eitan, Bernstein-Molho Rinat, Tirosh Am |
| Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET). Diagnostics (Basel, Switzerland) 2023 5 13 (9): . Giuseppe Lamberti, Natalie Prinzi, Alberto Bongiovanni, Mariangela Torniai, Elisa Andrini, Dario de Biase, Deborah Malvi, Mirta Mosca, Rossana Berardi, Toni Ibrahim, Sara Pusceddu, Davide Campa |
| Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: Impact of genotype and surgical approach on long-term postoperative outcomes. Surgery 2023 10 . Omair A Shariq, Vitor B Abrantes, Lauren Y Lu, Peter J Tebben, Trenton M Foster, Benzon M Dy, Melanie L Lyden, William F Young, Travis J McKenz |
| Peptide Receptor Radionuclide Therapy versus Capecitabine/Temozolomide for the Treatment of Metastatic Pancreatic Neuroendocrine Tumors. Cancers 2024 9 16 (17): . Rushabh Gujarathi, Joseph Tobias, Sara Abou Azar, Xavier M Keutgen, Chih-Yi Li |
| MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocrine-related cancer 2024 8 . Rushabh Gujarathi, Sara Abou Azar, Joseph Tobias, Blase N Polite, Namrata Setia, Nicholas Feinberg, Daniel E Appelbaum, Xavier Keutgen, Chih-Yi Li |
| Genotype-based prognosis prediction for MEN1-Related pancreatic neuroendocrine tumors in Korean patients a single-center retrospective study. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2024 12 . Juwan Kim, Seung Soo Hong, Sung Hyun Kim, Ho Kyoung Hwang, Namki Hong, Yumie Rhee, Chang Moo Ka |
| Comparative targeted genome profiling between solid and liquid biopsies in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a proof-of-concept pilot study. Neuroendocrinology 2024 10 1-20. Irene Gagliardi, Federica Campolo, Patricia Borges de Souza, Lucrezia Rossi, Manuela Albertelli, Federica Grillo, Luigi Caputi, Massimiliano Mazza, Antongiulio Faggiano, Maria Chiara Zatel |
- Page last reviewed:Feb 1, 2024
- Content source: